BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9765778)

  • 1. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of complicated renal colic in patients treated with indinavir: value of double J stents].
    Van Glabeke E; Conort P; Chartier-Kastler E; Desrez G; Boyer C; Richard F
    Prog Urol; 1999 Jun; 9(3):470-3. PubMed ID: 10434319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merck pushes the envelope with once-daily indinavir.
    TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
    [No Abstract]   [Full Text] [Related]  

  • 4. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
    [No Abstract]   [Full Text] [Related]  

  • 5. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithiasis associated with protease inhibitors.
    Sundaram CP; Saltzman B
    J Endourol; 1999 May; 13(4):309-12. PubMed ID: 10405912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritonavir and indinavir one year later.
    TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
    [No Abstract]   [Full Text] [Related]  

  • 8. Indinavir urinary stones as origin of upper urinary tract obstruction.
    John H; Müller NJ; Opravil M; Hauri D
    Urol Int; 1997; 59(4):257-9. PubMed ID: 9444746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary stones in HIV-1-positive patients treated with indinavir.
    Daudon M; Estépa L; Viard JP; Joly D; Jungers P
    Lancet; 1997 May; 349(9061):1294-5. PubMed ID: 9142068
    [No Abstract]   [Full Text] [Related]  

  • 10. Urolithiasis and the protease inhibitor indinavir.
    Hermieu J; Prévot M; Ravery V; Sauty L; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Eur Urol; 1999; 35(3):239-41. PubMed ID: 10072627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ureteral lithiasis caused by Indinavir].
    Valero G; Leyton R; Valenzuela A
    Rev Med Chil; 2002 May; 130(5):557-9. PubMed ID: 12143277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
    Pollmann H; Richter H; Jürgens H
    Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450
    [No Abstract]   [Full Text] [Related]  

  • 13. Protease inhibitors and urolithiasis.
    Sutherland SE; Reigle MD; Seftel AD; Resnick MI
    J Urol; 1997 Jul; 158(1):31-3. PubMed ID: 9186316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir (Crixivan).
    Res Initiat Treat Action; 2000 Mar; 6(1):28-9. PubMed ID: 11708184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of HIV infections and AIDS with protease inhibitor and two nucleoside analogs].
    Jensen-Fangel S; Larsen L; Thomsen HF; Nielsen LP; Black FT; Obel N
    Ugeskr Laeger; 1999 Mar; 161(12):1751-4. PubMed ID: 10210974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid development of indinavir-induced asymptomatic crystalluria in a human immunodeficiency virus-negative patient.
    Antony SJ
    Clin Infect Dis; 1998 Oct; 27(4):911-2. PubMed ID: 9798063
    [No Abstract]   [Full Text] [Related]  

  • 17. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indinavir and renal lithiasis].
    Traba Villameytide ML; Fernández-Guerrero M
    Actas Urol Esp; 2004; 28(7):523-6. PubMed ID: 15384277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
    Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM;
    Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
    Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
    Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.